` PLRM (Palram Industries 1990 Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

P
PLRM
vs
T
Tel Aviv 355

Over the past 12 months, PLRM has underperformed Tel Aviv 355, delivering a return of -42% compared to the Tel Aviv 355's +58% growth.

Stocks Performance
PLRM vs Tel Aviv 355

Loading
PLRM
Tel Aviv 355
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PLRM vs Tel Aviv 355

Loading
PLRM
Tel Aviv 355
Difference
www.alphaspread.com

Performance By Year
PLRM vs Tel Aviv 355

Loading
PLRM
Tel Aviv 355
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Palram Industries 1990 Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Palram Industries 1990 Ltd
Glance View

Market Cap
1.5B ILS
Industry
Chemicals

Palram Industries (1990) Ltd. engages in the development, production, and marketing of rigid thermoplastic panels produced by extrusion using polymers, the main ones of which are PVC and polycarbonate. The company manufactures extruded thermoplastic sheets from polycarbonate, polyvinyl chloride (PVC) and other materials. Its products are divided into five segments: Flat Sheets, Corrugated Sheets, Panel Systems, Specialty Products, and Finished Products. Its thermoplastic sheet products are designed to suit a diverse range of applications in the advertising, agricultural, construction, do-it-yourself, glazing and fabrication markets. The company operates a number of subsidiaries in such countries as the United States, Mexico, France, Israel, Australia, the Republic of South Africa, the United Kingdom, China, Hong Kong, India and Germany.

PLRM Intrinsic Value
7 102.95 ILS
Undervaluation 21%
Intrinsic Value
Price
P
Back to Top